학술논문

SCD1 is a potent therapeutic target in MYC-amplified group 3 medulloblastoma
Document Type
Journal
Source
MOLECULAR CANCER THERAPEUTICS; DEC 2023, 22 12, 2p. Supplement: S
Subject
Language
English
ISSN
15388514